Compare CORT & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | CWST |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 6.4B |
| IPO Year | 2001 | 1997 |
| Metric | CORT | CWST |
|---|---|---|
| Price | $121.58 | $94.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $96.50 | ★ $115.71 |
| AVG Volume (30 Days) | ★ 1.1M | 508.9K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | $761,407,000.00 | ★ $1,836,841,000.00 |
| Revenue This Year | $26.08 | $10.95 |
| Revenue Next Year | $26.98 | $6.97 |
| P/E Ratio | $1,358.33 | ★ N/A |
| Revenue Growth | 12.79 | ★ 17.95 |
| 52 Week Low | $28.66 | $74.05 |
| 52 Week High | $123.44 | $107.96 |
| Indicator | CORT | CWST |
|---|---|---|
| Relative Strength Index (RSI) | 68.94 | 53.68 |
| Support Level | $77.73 | $88.45 |
| Resistance Level | $122.21 | $93.13 |
| Average True Range (ATR) | 3.31 | 2.41 |
| MACD | 0.17 | 0.29 |
| Stochastic Oscillator | 85.66 | 74.78 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.